-
1
-
-
26644450484
-
Booming prescription drug expenditure: A population-based analysis of age dynamics
-
Morgan SG. Booming prescription drug expenditure: a population-based analysis of age dynamics. Med Care. 2005;43:996-1008.
-
(2005)
Med Care
, vol.43
, pp. 996-1008
-
-
Morgan, S.G.1
-
2
-
-
77954932009
-
Drugs costing Canada $25 billion annually: CIHI
-
Sylvain M. Drugs costing Canada $25 billion annually: CIHI. Med Post. 2006;42(19):5.
-
(2006)
Med Post
, vol.42
, Issue.19
, pp. 5
-
-
Sylvain, M.1
-
3
-
-
77954912026
-
Global drug plan trends
-
Dickson M. Global drug plan trends. Benefits Canada. 2006;30(2):F2.
-
(2006)
Benefits Canada
, vol.30
, Issue.2
-
-
Dickson, M.1
-
4
-
-
0642367859
-
Assessing the effect of Taiwan's outpatient prescription drug co-payment policy in the elderly
-
Liu SZ, Romeis JC. Assessing the effect of Taiwan's outpatient prescription drug co-payment policy in the elderly. Med Care. 2003;41:1331-1342.
-
(2003)
Med Care
, vol.41
, pp. 1331-1342
-
-
Liu, S.Z.1
Romeis, J.C.2
-
5
-
-
0038387463
-
Taiwan's new National Health Insurance program: Genesis and experience so far
-
Cheng TM. Taiwan's new National Health Insurance program: genesis and experience so far. Health Aff. 2003;22(3):61-76.
-
(2003)
Health Aff
, vol.22
, Issue.3
, pp. 61-76
-
-
Cheng, T.M.1
-
6
-
-
0036884966
-
Does the implementation of responsibility centers, total quality management, and physician fee programs improve hospital efficiency - Evidence from Taiwan hospitals
-
Chu HL, Liu SZ, Yaung CL, Romeis JC. Does the implementation of responsibility centers, total quality management, and physician fee programs improve hospital efficiency - evidence from Taiwan hospitals. Med Care. 2002;40:1233-1237.
-
(2002)
Med Care
, vol.40
, pp. 1233-1237
-
-
Chu, H.L.1
Liu, S.Z.2
Yaung, C.L.3
Romeis, J.C.4
-
7
-
-
0037316656
-
The initial effects of physician compensation programs in Taiwan hospitals: Implications for staff model HMOs
-
Chu HL, Liu SZ, Romeis JC. The initial effects of physician compensation programs in Taiwan hospitals: implications for staff model HMOs. Health Care Manag Sci. 2003;6(1):17-26.
-
(2003)
Health Care Manag Sci
, vol.6
, Issue.1
, pp. 17-26
-
-
Chu, H.L.1
Liu, S.Z.2
Romeis, J.C.3
-
8
-
-
0037076037
-
Outcomes of reference pricing for angiotensin-converting inhibitors
-
Schneeweiss S, Walker AM, Glynn RJ, et al. Outcomes of reference pricing for angiotensin-converting inhibitors. N Engl J Med. 2002;346:822-829.
-
(2002)
N Engl J Med
, vol.346
, pp. 822-829
-
-
Schneeweiss, S.1
Walker, A.M.2
Glynn, R.J.3
-
9
-
-
0037711369
-
Reference pricing for drugs: Is it compatible with U.S. health care?
-
DOI 10.1377/hlthaff.22.3.16
-
Kanavos P, Reinhardt U. Reference pricing for drugs: is it compatible with U.S. health care. Health Aff. 2003;22(3):16-30. (Pubitemid 41388740)
-
(2003)
Health Affairs
, vol.22
, Issue.3
, pp. 16-30
-
-
Kanavos, P.1
Reinhardt, U.2
-
10
-
-
0035346759
-
Pharmaceutical cost control in Canada: Does it work?
-
Menon D. Pharmaceutical cost control in Canada: does it work? Health Aff. 2001;20(3):92-103.
-
(2001)
Health Aff
, vol.20
, Issue.3
, pp. 92-103
-
-
Menon, D.1
-
11
-
-
0005784374
-
Financial incentives and drug spending in managed care
-
Hillman AL, Pauly MV, Escarce JJ, et al. Financial incentives and drug spending in managed care. Health Aff. 1999;18(2):189-200.
-
(1999)
Health Aff
, vol.18
, Issue.2
, pp. 189-200
-
-
Hillman, A.L.1
Pauly, M.V.2
Escarce, J.J.3
|